ProQR Therapeutics N.V. buy HC Wainwright
Start price
10.05.24
/
50%
€1.93
Target price
10.05.25
€4.64
Performance (%)
-8.33%
Price
03.10.24
€1.58
Summary
This prediction is currently active. With a performance of -8.33%, the BUY prediction for ProQR Therapeutics N.V. by HC_Wainwright is down slightly. This prediction currently runs until 10.05.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
ProQR Therapeutics N.V. | -0.938% | -0.938% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by HC_Wainwright for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
Stopped prediction by HC_Wainwright for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.30
07.08.23
07.08.23
€4.55
07.08.24
07.08.24
25.38%
08.08.24
08.08.24